The Only Hepatic-Derived Wound Matrix Primed for Cellular Integration
MIRODERM® is a non-crosslinked acellular wound matrix, derived from the highly vascularized porcine liver. It is intended for the management of wounds, including partial and full-thickness wounds; pressure ulcers; chronic vascular ulcers; diabetic ulcers; tunneled, undermined wounds; trauma wounds; drainage wounds; and surgical wounds.
Studies show MIRODERM Biologic Matrix boosts integration and maturation.
|A pilot study to evaluate the effects of perfusion decellularized porcine hepatic-derived wound matrix on difficult-to-heal diabetic foot ulcers||Robert Fridman, DPM||WOUNDS 2017;29(10):317-323||Read Here|
|Treatment of Hard-to-Heal Diabetic Foot Ulcers with a Novel Decellularized Hepatic-Derived Wound Matrix: Outcomes from a Prospective Multicenter Trial||Robert Fridman, Payam Rafat, Carl C Van Gils, Deena Horn, Dean Vayser, C Jake Lambert, Jr||SAWC 2019 Meeting||Read Here|
|ITEM ID||SIZE||TOTAL cm2|
|BLM-200-02-0815||8 x 15 cm||120|
|BLM-200-02-0710||7 x 10 cm||70|
|BLM-200-02-0808||8 x 8 cm||64|
|BLM-200-02-0505||5 x 5 cm||25|
|BLM-200-02-0307||3 x 7 cm||21|
|BLM-200-02-0404||4 x 4 cm||16|
|BLM-200-02-0303||3 x 3 cm||9|
|BLM-200-02-0203||2 x 3 cm||6|
|BLM-200-02-0202||2 x 2 cm||4|
|MIRODERM Fenestrated Plus|
|BLM-200-03-0815||8 x 15 cm||120|
|BLM-200-03-0710||7 x 10 cm||70|
|BLM-200-03-0808||8 x 8 cm||64|
|BLM-200-03-0505||5 x 5 cm||25|
|BLM-200-03-0307||3 x 7 cm||21|
|BLM-200-03-0404||4 x 4 cm||16|
|BLM-200-03-0303||3 x 3 cm||9|
MIRODERM Fenestrated and MIRODERM Fenestrated Plus are processed and stored in a phosphate buffered aqueous solution, packaged in an inner sterile pouch and outer non-sterile pouch, and sterilized with electron beam irradiation. The product comes in a variety of sizes and is intended for use only by trained medical professionals who are familiar with wound procedures and techniques involving the use of a wound matrix. Federal (U.S.A.) law restricts this product to sale by or on the order of a physician.
MIRODERM Biologic Wound Matrix (Fenestrated and Fenestrated Plus) is indicated for the management of wounds, including: partial and full-thickness wounds; pressure ulcers; venous ulcers; chronic vascular ulcers; diabetic ulcers; tunneled, undermined wounds; trauma-wounds (abrasion lacerations, second-degree burns, skin tears); drainage wounds; and surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric wound dehiscence).
See IFU for full prescribing information, including indications, contraindications, precautions, potential complications, and recommended application instructions.
Designed for The Management of Advanced Wounds
- Our proprietary perfusion decellularization results in a robust collagen scaffold manufactured into 16 different size configurations to meet the individual patient’s clinical needs.
- Variety of clinical applications which include: the management of partial and full-thickness wounds including pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, tunneled wounds, trauma wounds, draining wounds, and surgical wounds.
MIRODERM has natural vascular pathways and an open collagen matrix that facilitates cellular integration and remodeling in the management of advanced wounds.
Our perfusion decellularization technology facilitates rapid access to the whole organ. By cannulating the native vasculature and perfusing a mild detergent solution through the native blood vessels. This is in contrast to immersing the organ as in immersion decellularization.